Table 1.
CD1a | CD68 | CD163 | CD3 | CD56 | |
---|---|---|---|---|---|
CD1a | |||||
R | 0.094 | 0.082 | 0.081 | 0.217a | |
p | 0.231 | 0.294 | 0.294 | 0.007 | |
n | 164 | 165 | 171 | 155 | |
CD68 | |||||
R | 0.094 | 0.266b | 0.217a | 0.174a | |
p | 0.231 | 0.001 | 0.050 | 0.033 | |
n | 164 | 161 | 164 | 150 | |
CD163 | |||||
R | 0.082 | 0.266b | 0.366b | 0.080 | |
p | 0.294 | 0.001 | <0.001 | 0.329 | |
n | 165 | 161 | 165 | 151 | |
MARCO | |||||
R | 0.081 | 0.274b | 0.074 | 0.092 | −0.038 |
p | 0.298 | 0.001 | 0.346 | 0.234 | 0.298 |
n | 166 | 164 | 164 | 170 | 170 |
R Spearman’s correlation coefficient, p p value, n number of cases available for analysis
aSignificance at the 5% level
bSignificance at the 1% level